TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model.
Immune checkpoint inhibitors have demonstrated, over the recent years, impressive clinical response in cancer patients, but some patients do not respond at all to checkpoint blockade, exhibiting primary resistance. Primary resistance to PD-1 blockade is reported to occur under conditions of immunosu...
Enregistré dans:
Auteurs principaux: | Nourridine Siewe, Avner Friedman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7dca81abbfbf4d83b65009791af3b7f8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
par: Grégoire de Streel, et autres
Publié: (2020) -
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
par: Florie Bertrand, et autres
Publié: (2017) -
Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade
par: Catherine T. Flores, et autres
Publié: (2018) -
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
par: Yong Liang, et autres
Publié: (2018) -
Correction: Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis
Publié: (2021)